California senators have unanimously approved a bipartisan bill to create a psilocybin pilot program for military veterans and first responders.
On Wednesday, members of the Senate Health Committee advanced the legislation from Sens. Josh Becker (D) and Brian Jones (R), with amendments, in a 7-0 vote.
The proposal would establish a pilot program under the University of California (UC) system to study and develop “psilocybin services” for eligible patients in up to five counties across the state.
The universities would be responsible for “protocol design, institutional review board approvals, training of psilocybin facilitators, data collection, and reporting” of the pilot program.
“The bill would require each local pilot program to partner with local mental health clinics, hospice programs, veterans facilities, or other community-based providers that provide services and care to the target population,” the measure, as introduced in January, says. “This bill would require the agency to report specified information about the pilot program to the Legislature by January 15, 2030.”
Under the legislation, the state would establish a “Veterans and First Responders Research Pilot Special Fund,” with continuous appropriations to fund the work.
“SB 751 responds to crisis we cannot ignore. Every day, an average of 17.6 veterans die by suicide. First responders—those who run towards dangers to protect the rest of us—are more likely to die by suicide than in the line of duty,” Becker said. “These are individuals who’ve experienced repeated trauma and, too often, existing mental health treatments simply don’t work for them.”
Many are turning to underground or unregulated sources of psilocybin, or even traveling abroad, to seek relief that only places them at risk,” he said. “It signals a serious gap in our system of care. This bill is a step towards addressing that gap responsibly and safely.”
A findings section of the legislation—which is also cosponsored by eight other lawmakers, including longtime psychedelics reform advocate Sen. Scott Wiener (D)—states that research “suggests that psilocybin and psilocyn, when used in a controlled setting, may offer significant benefits in treating mental health disorders, particularly those related to trauma and stress.”